연구성과로 돌아가기

2024 연구성과별 연구자 정보 (726 / 2344)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Croft, N. M. Croft, NM 5 Royal London Childrens Hosp Barts Hlth NHS Trust, Paediat Gastroenterol, London, England
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Kang, B. Kang, B 6 Kyungpook Natl Univ, Sch Med, Dept Pediat, Daegu, South Korea
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Granot, M. Granot, M 7 Tel Aviv Univ, Fac Med, Tel Aviv, Israel
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Granot, M. Granot, M 7 Edmond & Lily Safra Childrens Hosp, Sheba Med Ctr, Pediat Gastroenterol & Nutr Unit, Tel Hashomer, Israel
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN D'Arcangelo, G. D'Arcangelo, G 8 Sapienza Univ Rome, Dept Womens & Childrens Hlth, Umberto I Hosp, Pediat Gastroenterol & Liver Unit, Rome, Italy
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Spencer, E. Spencer, E 9 Icahn Sch Med Mt Sinai, Dept Pediat, Div Pediat Gastroenterol & Nutr, New York, NY USA
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Kolho, K. L. Kolho, KL 10 Univ Helsinki, Childrens Hosp, Helsinki, Finland
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Kolho, K. L. Kolho, KL 10 HUS, Dept Pediat Gastroenterol, Helsinki, Finland
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Yeh, P. J. Yeh, PJ 11 Univ Oxford, Translat Gastroenterol Unit, Oxford, England
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Sladek, M. Sladek, M 12 Jagiellonian Univ, Krakow, Poland
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Sladek, M. Sladek, M 12 Polish Amer Childrens Hosp, Krakow, Poland
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Scarallo, L. Scarallo, L 13 Meyer Children Hosp IRCCS, Gastroenterol & Nutr Unit, Florence, Italy
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Scarallo, L. Scarallo, L 13 Univ Florence, Dept NEUROFARBA, Florence, Italy
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Palomino Perez, L. Pérez, LP 14 Hosp Infantil Univ Nino Jesus, Dept Gastroenterol & Nutr, Madrid, Spain
Efficacy and safety of Adalimumab in Very Early-onset IBD- A Multicentre Study from the Paediatric IBD Porto Group of ESPGHAN Afzal, N. Afzal, N 15 Southampton Childrens Hosp, Dept Paediat Gastroenterol, Southampton, Hants, England
페이지 이동: